drugset / Trial / NCT02717208
Phase 1 Study for Safety and Tolerability of HL036
RandomizedParallel-groupDouble-blindTreatment
Summary
To evaluate the safety, local tolerability and pharmacokinetic characteristics after administration of eye-drop HL036 in healthy Korean male volunteers
Timeline
- Start
- 2016-02
- Primary completion
- 2016-06
- Completion
- 2016-06
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | HL036 | Unknown | 0.5 mg/ml | Other |
| Comparator | HL036 | Unknown | 5 mg/ml | Other |